News
The French company Orano says litigation is now its only possible recourse after Niger's Council of Ministers announced plans ...
MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med Promising tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results